Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
for Resistant Hypertension
Sites in Stanford, Orange +3 more locations
Sponsor: DeepQure Inc.
Sex: All·Age: 22 - 80
Code: NCT06526858·Recruiting·Listed Jul 2024